CureLab Oncology
Phase 1/2CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics.
Founded
2015
Focus
Biologics
About
CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics.
Funding History
2Total raised: $15.5M
Series A$15MUndisclosedOct 15, 2022
Grant$500KNational Institutes of HealthJun 15, 2020
Company Info
TypePrivate
Founded2015
LocationBoston, United States
StagePhase 1/2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile